Today, the Canadian Cancer Society says Mitchell can count himself among the growing number of people who are surviving blood cancer due to precision medicine — treatments based on a person’s genes or other unique features of the cancer the person has. New statistics released Wednesday sugge...
Bone Marrow and Blood Cells Structure and Function, 724 Dysfunction/Responses to Injury, 730 Portals of Entry/Pathways of Spread, 744 Defense Mechanisms/Barrier Systems, 744 Disorders of Domestic Animals, 744 Disorders of Horses, 758 Disorders of Ruminants (Cattle, Sheep, and Goats), 758 Disorders...
The immune system has a central role in preventing carcinogenesis. Alteration of systemic immune cell levels may increase cancer risk. However, the extent to which common genetic variation influences blood traits and cancer risk remains largely undetermi
Cancersurvivallife spanmonthly risk of a mortalityperiodicityblood stem cellsapproximationThe purpose of the work was the comparative study of dynamic relations between the fluctuation of survival rate and presence of hematopoietic progenitor cells in circulating blood of oncologic patients in the final ...
Wu ,et al.: Advance in blood diseases and bone marrow microvessel25JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE / JAN-MAR 2014 / VOL 2 | ISSUE 1acute myelogenous leukemias: Therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab. ClinCancer Res 2004;10:3577-85.12.Ho...
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood. 2011;118(5):1413-1420. doi:10.1182/blood-2011-01-331835...
using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and ...
Since October 2017, bone marrow samples of 2434 patients with diagnosis of AML (as per WHO 2016 criteria) were analyzed in the PETHEMA central laboratories (PLATAFO-LMA project). Pediatric patients (<18 years) and acute promyelocytic leukemias were excluded, and all eligible patients were register...
Accompanying effects on immune cell populations are consistent with a greater ability of G-BM to promote tolerance in allogeneic recipients, and this could contribute to a lower rate of chronic graft-versus-host disease.Previous article in issue Next article in issue Keywords G-CSF Bone marrow ...
Primary cerebral tumors were identified using the Swedish and Danish cancer registers. Reporting of diagnoses, procedures, blood donations, and transfusions to the data sources used in this study is mandated by law, which helps ensure their completeness. Data were kept and analyzed separately in ...